Syntaxis Company
%20.jpg)
Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke.
Technology:
NeuroTech
Headquarters:
Lund, Skane Lan, Sweden
Total Funding:
€200K
Last Funding Type:
Seed
Founded Date:
2017-01-01
Investors Number:
2
Industry:
Biotechnology, Health Care, Science and Engineering
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Investor Type:
For Profit